Dr Arijit Bishnu is the best haemato- onchologist in Siliguri, with great skills and friendly nature.
Targeted therapy is an advanced form of treatment designed to attack specific molecules involved in the growth and survival of abnormal blood cells. Unlike traditional chemotherapy, which affects both healthy and diseased cells, targeted therapy focuses only on cancerous or abnormal pathways—making it more precise, effective, and often better tolerated. Though widely used in blood cancers, targeted therapy is also finding emerging applications in non-cancerous hematologic conditions where specific genetic or molecular abnormalities are involved. Rather than attacking all rapidly dividing cells, targeted therapies are designed to interfere with specific pathways or proteins that are active in diseased cells—minimizing damage to normal cells. This makes the treatment both more precise and better tolerated.
These therapies are especially important in conditions where distinct genetic mutations or surface markers have been identified. For example, in Chronic Myeloid Leukemia (CML), the BCR-ABL gene fusion is targeted by tyrosine kinase inhibitors like imatinib. Similarly, Chronic Lymphocytic Leukemia (CLL) may be treated with drugs targeting BCL2 or BTK proteins.
Dr. Arijit Bishnu and his team use advanced diagnostics, such as genetic testing and molecular profiling, to determine whether targeted therapy is right for a patient. Treatment is then closely monitored and adjusted based on response and tolerance :
Medical History Review: Understanding your symptoms, lifestyle, and medical history to assess any underlying conditions that may be contributing to the menstrual issues.
Treatment of specific blood cancers - Used in conditions such as chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), certain lymphomas, and myeloproliferative neoplasms.
Molecular targeting - Focuses on proteins, genes, or cellular pathways that drive abnormal blood cell growth or survival.
Genetic testing required -Requires molecular diagnostics to identify the presence of targetable mutations or markers.
Fewer side effects than chemotherapy - Typically spares normal cells, leading to lower risk of hair loss, nausea, or widespread immune suppression.
Key advancement in personalized medicine - Allows hematologists to match treatment to each patient’s unique disease profile for optimal outcomes.
Dr. Arijit Bishnu specializes in the diagnosis and treatment of blood disorders, including anemia, leukemia, lymphoma, and clotting abnormalities. With expertise in advanced haematological care, he is dedicated to providing accurate diagnosis and personalized treatment plans for optimal patient health.
© Dr. Arijit Bishnu. All Rights Reserved.
Designed by Digiex Web